drugset / Trial / NCT01513200
Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers With and Without Bendavia
RandomizedCrossoverQuadruple-blindBasic science
Summary
This will be a phase 1 randomized, double-blind crossover trial enrolling approximately 12 healthy volunteers to assess whether intravenous (IV) UFH and IV Bendavia administered together have any significant impact on the pharmacodynamic effects of UFH and the pharmacokinetics of Bendavia.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elamipretide | Peptide | 0.25 mg/kg | Intravenous |
| Subject | Heparin | Other / unclassified | 12 iu/kg | Intravenous |
Indications
No indication recorded.